MNKD MannKind Corporation - Common Stock
$3,90
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 5, 2026
Zakres 52 tyg.
$2–$7
39% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$8
+105% upside
P/E (TTM)
194.8
ROE
-11.1%
Marża Zysku Netto
1.7%
O MannKind Corporation - Common Stock Przegląd firmy z Wikipedii
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
Czytaj więcej
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
MNKD Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$3.90
Kapitalizacja Rynkowa
$1.20B
P/E (TTM)
194.8
EPS (TTM)
$0.02
Przychody (TTM)
$349M
Stopa dywidendy
—
ROE
-11.1%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $7
MNKD Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$349M
2016-12-31
→
2025-12-31
EPS
$0.02
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
$14M
2018-12-31
→
2025-12-31
Marże
1.7%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
MNKD
Mediana porównawcza
P/E (TTM)
194.8
—
P/S (TTM)
3.4
10.7
P/B
-23.5
5.2
Price / FCF (Cena / FCF)
87.6
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
MNKD
Mediana porównawcza
Operating Margin (Marża Operacyjna)
11.1%
—
Net Profit Margin (Marża Zysku Netto)
1.7%
-140.3%
ROA
0.99%
-44.7%
ROE
-11.1%
-51.5%
ROIC
-316.9%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
MNKD
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
1.7
9.5
Quick Ratio (Wskaźnik Szybkości)
1.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
MNKD
Mediana porównawcza
Revenue YoY (Przychody R/R)
22.2%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
51.8%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
39.9%
—
EPS YoY
-80.0%
—
Net Income YoY (Zysk Netto R/R)
-78.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
MNKD
Mediana porównawcza
MNKD Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 4 28,6%
- Kup 8 57,1%
- Trzymaj 2 14,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
8 analityków · 2026-08-17
Mediana
$7.50
← Poniżej wszystkich celów
$3.90
Niski
$4.75
Wysoki
$13.00
Średni cel
$7.50
+92,6%
Średnia cel
$7.97
+104,6%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.03%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.06 | $-0.00 | -0.06% |
| 31 marca 2026 | $-0.05 | $-0.00 | -0.05% |
| 31 grudnia 2025 | $-0.05 | $0.01 | -0.06% |
| 30 września 2025 | $0.07 | $0.02 | 0.05% |
| 30 czerwca 2025 | $0.00 | $0.05 | -0.05% |
| 31 marca 2025 | $0.04 | $0.04 | -0.00% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
Bilans 28
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
Przepływy pieniężne 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
Stopy Wzrostu 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
Wycena (TTM) 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $349M | $286M | $199M | $100M | $75M |
| Marża Operacyjna % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| Zysk netto | $6M | $28M | $-12M | $-87M | $-81M |
| Rozwodniony EPS | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| Wskaźnik Szybkości | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $14M | $33M | $-8M | $-88M | $-73M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
- MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
- H.C. Wainwright i Wells Fargo podnoszą docelowe ceny akcji MannKind (MNKD)
- Czy MannKind Corporation (MNKD) jest jedną z popularnych akcji spekulacyjnych na Robinhood do kupienia?
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 271 emitentów · $560.6M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 55 (+12 vs poprzedni kw.) | 37 (-11 vs poprzedni kw.) | 93 (+10 vs poprzedni kw.) | 61 (-8 vs poprzedni kw.) | +24.2M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Rubric Capital Management LP | $76 680 000 | 18 000 000 | 13,68% | Akcje |
| STATE STREET CORP | $68 901 423 | 16 174 043 | 12,29% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $56 101 610 | 13 169 392 | 10,01% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $29 027 881 | 6 812 460 | 5,18% | Akcje |
| Frazier Life Sciences Management, L.P. | $28 116 000 | 6 600 000 | 5,01% | Akcje |
| Deep Track Capital, LP | $25 560 000 | 6 000 000 | 4,56% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $23 099 232 | 5 422 355 | 4,12% | Akcje |
| 180 WEALTH ADVISORS, LLC | $21 126 835 | 4 959 351 | 3,77% | Akcje |
| FMR LLC | $17 455 563 | 4 097 550 | 3,11% | Akcje |
| TSP Capital Management Group, LLC | $16 923 596 | 3 972 675 | 3,02% | Akcje |
| BRAIDWELL LP | $14 732 908 | 3 458 429 | 2,63% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12 789 240 | 3 002 169 | 2,28% | Akcje |
| VANGUARD GROUP INC | $11 888 249 | 2 096 693 | 2,12% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $11 475 213 | 2 693 712 | 2,05% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11 070 577 | 2 598 727 | 1,97% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $9 358 279 | 2 196 779 | 1,67% | Akcje |
| BANK OF AMERICA CORP /DE/ | $8 689 749 | 2 039 847 | 1,55% | Akcje |
| GOLDMAN SACHS GROUP INC | $6 332 618 | 1 486 530 | 1,13% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 030 221 | 1 180 803 | 0,90% | Akcje |
| BlackRock, Inc. | $4 766 748 | 1 118 955 | 0,85% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $4 486 321 | 1 053 127 | 0,80% | Akcje |
| Caption Management, LLC | $4 260 000 | 1 000 000 | 0,76% | Opcja sprzedaży |
| J. Goldman & Co LP | $3 478 669 | 816 589 | 0,62% | Akcje |
| WELLS FARGO & COMPANY/MN | $3 473 987 | 815 490 | 0,62% | Akcje |
| SCOPIA CAPITAL MANAGEMENT LP | $2 960 534 | 694 961 | 0,53% | Akcje |
| Balyasny Asset Management L.P. | $2 914 296 | 684 107 | 0,52% | Akcje |
| TWO SIGMA ADVISERS, LP | $2 897 166 | 510 964 | 0,52% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $2 771 407 | 650 565 | 0,49% | Akcje |
| Swiss National Bank | $2 502 324 | 587 400 | 0,45% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $2 177 052 | 511 045 | 0,39% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2 106 540 | 494 493 | 0,38% | Akcje |
| 1492 Capital Management LLC | $2 052 136 | 481 722 | 0,37% | Akcje |
| Mariner, LLC | $2 020 189 | 474 236 | 0,36% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $1 836 597 | 431 126 | 0,33% | Akcje |
| Schonfeld Strategic Advisors LLC | $1 774 216 | 416 483 | 0,32% | Akcje |
| Squarepoint Ops LLC | $1 759 644 | 413 062 | 0,31% | Akcje |
| Jefferies Financial Group Inc. | $1 694 202 | 397 700 | 0,30% | Akcje |
| ExodusPoint Capital Management, LP | $1 666 261 | 391 141 | 0,30% | Akcje |
| JANE STREET GROUP, LLC | $1 658 418 | 389 300 | 0,30% | Opcja kupna |
| Man Group plc | $1 624 023 | 381 226 | 0,29% | Akcje |
| RHUMBLINE ADVISERS | $1 604 647 | 376 681 | 0,29% | Akcje |
| IEQ CAPITAL, LLC | $1 544 607 | 362 584 | 0,28% | Akcje |
| CITIGROUP INC | $1 499 243 | 351 935 | 0,27% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 423 692 | 334 200 | 0,25% | Opcja sprzedaży |
| Bank of New York Mellon Corp | $1 422 222 | 333 855 | 0,25% | Akcje |
| Caption Management, LLC | $1 414 231 | 331 979 | 0,25% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1 359 221 | 319 066 | 0,24% | Akcje |
| ALPS ADVISORS INC | $1 330 615 | 312 351 | 0,24% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 216 230 | 285 500 | 0,22% | Opcja kupna |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1 029 075 | 241 567 | 0,18% | Akcje |
| BARCLAYS PLC | $1 029 062 | 241 564 | 0,18% | Akcje |
| Rafferty Asset Management, LLC | $1 008 640 | 236 770 | 0,18% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $1 002 715 | 235 379 | 0,18% | Akcje |
| Aaron Wealth Advisors LLC | $1 000 878 | 234 948 | 0,18% | Akcje |
| HSBC HOLDINGS PLC | $998 560 | 230 881 | 0,18% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930 294 | 379 712 | 0,17% | Akcje |
| CITADEL ADVISORS LLC | $928 680 | 218 000 | 0,17% | Opcja kupna |
| CITADEL ADVISORS LLC | $898 860 | 211 000 | 0,16% | Opcja sprzedaży |
| Bruce & Co., Inc. | $831 011 | 195 073 | 0,15% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $775 060 | 181 939 | 0,14% | Akcje |
| MetLife Investment Management, LLC | $766 442 | 179 916 | 0,14% | Akcje |
| FRANKLIN RESOURCES INC | $755 021 | 177 235 | 0,13% | Akcje |
| Stonepine Capital Management, LLC | $750 000 | 250 000 | 0,13% | Opcja kupna |
| UBS Group AG | $715 978 | 168 070 | 0,13% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $693 375 | 283 010 | 0,12% | Akcje |
| MORGAN STANLEY | $651 282 | 152 883 | 0,12% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $640 657 | 150 389 | 0,11% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $632 009 | 148 359 | 0,11% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613 437 | 171 372 | 0,11% | Akcje |
| Jain Global LLC | $604 673 | 141 942 | 0,11% | Akcje |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590 457 | 138 605 | 0,11% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $574 538 | 134 868 | 0,10% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570 354 | 133 886 | 0,10% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $557 723 | 130 921 | 0,10% | Akcje |
| PROFUND ADVISORS LLC | $517 726 | 121 532 | 0,09% | Akcje |
| Invesco Ltd. | $512 389 | 120 279 | 0,09% | Akcje |
| Vanguard Global Advisers, LLC | $509 833 | 119 679 | 0,09% | Akcje |
| KLP KAPITALFORVALTNING AS | $491 604 | 115 400 | 0,09% | Akcje |
| Gotham Asset Management, LLC | $452 463 | 106 212 | 0,08% | Akcje |
| State of New Jersey Common Pension Fund D | $403 171 | 94 641 | 0,07% | Akcje |
| State of Wyoming | $403 149 | 94 636 | 0,07% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $386 834 | 90 806 | 0,07% | Akcje |
| Amundi | $374 310 | 87 866 | 0,07% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373 478 | 87 671 | 0,07% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $359 966 | 84 499 | 0,06% | Akcje |
| ARIZONA STATE RETIREMENT SYSTEM | $344 050 | 80 763 | 0,06% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338 155 | 79 379 | 0,06% | Akcje |
| Aquatic Capital Management LLC | $335 300 | 78 709 | 0,06% | Akcje |
| Rockefeller Capital Management L.P. | $332 996 | 78 168 | 0,06% | Akcje |
| Vanguard Investments Australia, Ltd. | $314 929 | 73 927 | 0,06% | Akcje |
| JANUS HENDERSON GROUP PLC | $313 658 | 127 763 | 0,06% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312 203 | 73 287 | 0,06% | Akcje |
| Sequoia Financial Advisors, LLC | $296 935 | 69 703 | 0,05% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $284 653 | 66 820 | 0,05% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $280 421 | 65 827 | 0,05% | Akcje |
| China Universal Asset Management Co., Ltd. | $262 714 | 61 670 | 0,05% | Akcje |
| LPL Financial LLC | $260 060 | 61 047 | 0,05% | Akcje |
| SIMPLEX TRADING, LLC | $258 790 | 60 749 | 0,05% | Akcje |
| Cetera Investment Advisers | $241 546 | 56 701 | 0,04% | Akcje |
| Painted Porch Advisors LLC | $227 620 | 53 432 | 0,04% | Akcje |
Insiderzy spółki 43 insiderów · 27 dyrektorzy generalni · 18 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 15 lipca 2026 M | 2 433 779 | 1 | 4 | $-990 292 |
| Hakan Edstrom | President & CEO | 27 sierpnia 2015 A | 1 114 340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 15 lipca 2026 F | 318 668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 27 sierpnia 2015 A | 106 539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 15 lipca 2026 F | 343 398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 15 lipca 2026 M | 478 966 | 0 | 1 | $-94 448 |
| Stuart A Tross | Chief People & Workpl Officer | 15 lipca 2026 M | 1 058 142 | 0 | 2 | $-548 528 |
| David Thomson | EVP Genl Counsel & Secretary | 15 lipca 2026 M | 797 554 | 0 | 3 | $-930 755 |
| Ajay Ahuja | Chief Medical Officer | 23 marca 2026 A | 318 200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 15 lipca 2025 F | 349 841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 15 lipca 2025 F | 460 791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 27 sierpnia 2022 F | 745 233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 28 lutego 2022 A | 576 690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 27 sierpnia 2020 A | 167 119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 31 lipca 2020 P | 41 059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 25 lutego 2020 A | 83 972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 31 lipca 2019 P | 29 584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 14 maja 2019 A | 43 012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 10 sierpnia 2017 S | 2 924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 18 lutego 2016 A | 92 200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 22 sierpnia 2015 F | 1 005 990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 23 lutego 2015 F | 50 624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 3 marca 2012 F | 133 611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 16 listopada 2008 F | 204 401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 13 sierpnia 2008 A | 14 650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 8 grudnia 2006 A | 14 800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 19 sierpnia 2004 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | Dyrektor | 20 maja 2026 A | 265 600 | 0 | 0 | $0 |
| Jennifer Grancio | Dyrektor | 20 maja 2026 A | 244 815 | 0 | 0 | $0 |
| James Samuel Shannon | Dyrektor | 20 maja 2026 A | 64 635 | 0 | 0 | $0 |
| Michael A Friedman | Dyrektor | 20 maja 2026 A | 47 500 | 0 | 0 | $0 |
| Anthony C Hooper | Dyrektor | 20 maja 2026 A | 236 153 | 0 | 0 | $0 |
| Christine Mundkur | Dyrektor | 20 maja 2026 A | 254 493 | 0 | 0 | $0 |
| Ronald J Consiglio | Dyrektor | 20 maja 2026 A | 132 342 | 0 | 0 | $0 |
| Kent Kresa | Dyrektor | 15 maja 2024 A | 274 541 | 0 | 0 | $0 |
| Henry L Nordhoff | Dyrektor | 14 maja 2019 A | 103 426 | 0 | 0 | $0 |
| David Maccallum | Dyrektor | 16 maja 2018 A | 114 790 | 0 | 0 | $0 |
| Matthew J Pfeffer | Dyrektor | 28 sierpnia 2017 F | 81 961 | 0 | 0 | $0 |
| Abraham E Cohen | Dyrektor | 17 sierpnia 2012 S | 56 424 | 0 | 0 | $0 |
| Heather Hay Murren | Dyrektor | 13 sierpnia 2008 A | 10 100 | 0 | 0 | $0 |
| Kathleen Connell | Dyrektor | 25 maja 2006 A | — | 0 | 0 | $0 |
| Llew Keltner | Dyrektor | 25 maja 2006 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | 7 sierpnia 2026 S | 785 867 | 0 | 3 | $-427 369 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 zgłoszenia | 10 lipca 2012 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 31 stycznia 2006 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 41 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1,43% | 773 251 NS | 30 kwietnia 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,74% | 317 578 NS | 31 maja 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 29 662 SH | 8 sierpnia 2026 | Dziennie |
| AGNG · Global X Funds | 0,46% | 98 947 NS | 31 maja 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,34% | 625 921 NS | 30 kwietnia 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,11% | 64 525 NS | 31 maja 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 2 170 137 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,09% | 16 814 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 330 117 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,07% | 2 772 931 SH | 8 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,06% | 449 515 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,06% | 11 389 NS | 31 maja 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 114 273 NS | 30 kwietnia 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1 771 496 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,04% | 7 830 029 SH | 8 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,04% | 94 032 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,03% | 14 400 NS | 31 maja 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 132 607 NS | 30 kwietnia 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 1 466 402 NS | 31 maja 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 61 465 NS | 31 maja 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 874 372 SH | 8 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,02% | 13 557 SH | 8 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,02% | 11 261 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 135 688 NS | 30 kwietnia 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 638 128 NS | 30 kwietnia 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 11 390 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3 543 398 SH | 8 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,01% | 16 464 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12 000 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 286 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 452 118 NS | 30 kwietnia 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 27 701 NS | 30 kwietnia 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 1 330 NS | 31 maja 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 465 445 SH | 8 sierpnia 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 196 006 NS | 31 maja 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 83 220 SH | 8 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,00% | 10 345 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 32 093 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 14 557 NS | 30 kwietnia 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9 327 332 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26 184 SH | 8 sierpnia 2026 | Dziennie |